Literature DB >> 23587140

"Prion-like" templated misfolding in tauopathies.

Florence Clavaguera1, Isabelle Lavenir, Ben Falcon, Stephan Frank, Michel Goedert, Markus Tolnay.   

Abstract

The soluble microtubule-associated protein tau forms hyperphosphorylated, insoluble and filamentous inclusions in a number of neurodegenerative diseases referred to as "tauopathies." In Alzheimer's disease, tau pathology develops in a stereotypical manner, with the first lesions appearing in the locus coeruleus and entorhinal cortex, from where they appear to spread to the hippocampus and neocortex. Propagation of tau pathology is also a characteristic of argyrophilic grain disease, where the tau lesions spread throughout the limbic system. Significantly, isoform composition and morphology of tau filaments can differ between tauopathies, suggesting the existence of distinct tau strains. Extensive experimental findings indicate that prion-like mechanisms underly the pathogenesis of tauopathies.
© 2013 The Authors; Brain Pathology © 2013 International Society of Neuropathology.

Entities:  

Mesh:

Year:  2013        PMID: 23587140      PMCID: PMC8028860          DOI: 10.1111/bpa.12044

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  109 in total

1.  Proteasomal degradation of tau protein.

Authors:  Della C David; Robert Layfield; Louise Serpell; Yolanda Narain; Michel Goedert; Maria Grazia Spillantini
Journal:  J Neurochem       Date:  2002-10       Impact factor: 5.372

2.  Tau is a candidate gene for chromosome 17 frontotemporal dementia.

Authors:  P Poorkaj; T D Bird; E Wijsman; E Nemens; R M Garruto; L Anderson; A Andreadis; W C Wiederholt; M Raskind; G D Schellenberg
Journal:  Ann Neurol       Date:  1998-06       Impact factor: 10.422

3.  Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly.

Authors:  B L Goode; P E Denis; D Panda; M J Radeke; H P Miller; L Wilson; S C Feinstein
Journal:  Mol Biol Cell       Date:  1997-02       Impact factor: 4.138

4.  Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies.

Authors:  Matthew R Reynolds; Juan F Reyes; Yifan Fu; Eileen H Bigio; Angela L Guillozet-Bongaarts; Robert W Berry; Lester I Binder
Journal:  J Neurosci       Date:  2006-10-18       Impact factor: 6.167

5.  Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding.

Authors:  G T Bramblett; M Goedert; R Jakes; S E Merrick; J Q Trojanowski; V M Lee
Journal:  Neuron       Date:  1993-06       Impact factor: 17.173

6.  Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles.

Authors:  Jing L Guo; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2011-03-03       Impact factor: 5.157

Review 7.  Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies.

Authors:  Einar M Sigurdsson
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

8.  Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.

Authors:  Harald Hampel; Michael Ewers; Katharina Bürger; Peter Annas; Anette Mörtberg; Anna Bogstedt; Lutz Frölich; Johannes Schröder; Peter Schönknecht; Matthias W Riepe; Inga Kraft; Thomas Gasser; Thomas Leyhe; Hans-Jürgen Möller; Alexander Kurz; Hans Basun
Journal:  J Clin Psychiatry       Date:  2009-06       Impact factor: 4.384

9.  Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms.

Authors:  M Goedert; M G Spillantini; N J Cairns; R A Crowther
Journal:  Neuron       Date:  1992-01       Impact factor: 17.173

10.  Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau.

Authors:  M Goedert; C M Wischik; R A Crowther; J E Walker; A Klug
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

View more
  52 in total

Review 1.  Tau immunotherapy and imaging.

Authors:  Einar M Sigurdsson
Journal:  Neurodegener Dis       Date:  2013-09-11       Impact factor: 2.977

2.  Asparagine endopeptidase cleaves tau and promotes neurodegeneration.

Authors:  Hanna Rosenmann
Journal:  Nat Med       Date:  2014-11       Impact factor: 53.440

3.  Brain structural alterations are distributed following functional, anatomic and genetic connectivity.

Authors:  Franco Cauda; Andrea Nani; Jordi Manuello; Enrico Premi; Sara Palermo; Karina Tatu; Sergio Duca; Peter T Fox; Tommaso Costa
Journal:  Brain       Date:  2018-11-01       Impact factor: 13.501

4.  MRI signatures of the frontotemporal lobar degeneration continuum.

Authors:  Federica Agosta; Sebastiano Galantucci; Giuseppe Magnani; Alessandra Marcone; Daniele Martinelli; Maria Antonietta Volontè; Nilo Riva; Sandro Iannaccone; Pilar M Ferraro; Francesca Caso; Adriano Chiò; Giancarlo Comi; Andrea Falini; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2015-03-28       Impact factor: 5.038

5.  Pathological Alterations of Tau in Alzheimer's Disease and 3xTg-AD Mouse Brains.

Authors:  Longfei Li; Yanli Jiang; Wen Hu; Yunn Chyn Tung; Chunling Dai; Dandan Chu; Cheng-Xin Gong; Khalid Iqbal; Fei Liu
Journal:  Mol Neurobiol       Date:  2019-02-08       Impact factor: 5.590

Review 6.  Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-11-01       Impact factor: 10.005

Review 7.  Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Biochem Pharmacol       Date:  2014-01-10       Impact factor: 5.858

8.  Progressive Supranuclear Palsy and Corticobasal Degeneration.

Authors:  David G Coughlin; Dennis W Dickson; Keith A Josephs; Irene Litvan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  Biomarker modelling of early molecular changes in Alzheimer's disease.

Authors:  Ross W Paterson; Jamie Toombs; Catherine F Slattery; Jonathan M Schott; Henrik Zetterberg
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

Review 10.  The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy.

Authors:  Cheng-Cheng Zhang; Ang Xing; Meng-Shan Tan; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-09-12       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.